Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host intestinal mucosa, gut microbiota, and enteric pathogens represent a complex tripartite biological system rather than a single molecular target. The intestinal mucosa serves as a critical physical and immunological barrier, employing mucus layers and tight junctions to maintain separation between the host and the luminal environment (Source: National Center for Biotechnology Information (NCBI), "The Intestinal Barrier: A Fundamental Role in Health and Disease", 2021). The gut microbiota consists of trillions of commensal microorganisms that provide colonization resistance by competing with pathogens for niches and producing antimicrobial metabolites like short-chain fatty acids (Source: Nature Reviews Microbiology, "Mechanisms of colonization resistance", 2018). Enteric pathogens are specialized microorganisms that attempt to bypass these defenses to cause disease, often by inducing inflammation or damaging the epithelial lining (Source: PubMed, "Pathogen-microbiota-host interactions in the gut", 2020). Therapeutic approaches targeting this axis, such as probiotics or fecal microbiota transplants, focus on restoring ecological balance and barrier function. Given its multi-component nature involving various cell types and species, this entity is categorized as a biological interface or ecosystem.
Modulation of microbial community composition, enhancement of epithelial tight junction integrity, and competitive exclusion of pathogenic attachment.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal mucosa, gut microbiota, and enteric pathogens.